🔎 Trials Near Me

Home › Sexually Transmitted Infections › NCT06266416

IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)

RecruitingHealthy volunteers welcome

A Family-Based HIV Prevention Program for Black Men to Protect Black Girls

Who can join

Ages 13 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

AIM 1:

* Self-identify as African American, Black, or mixed race with African American or Black
* Speak English
* Males must identify as a current caregiver to girl enrolled in the study

AIM 2: All Community Based Organizations (CBO) directors and IMAGE liaisons will be eligible.

Exclusion Criteria:

AIM 1:

* Girl refuses to participate
* Inability to understand the consent/assent process
* Non-English speaking
* Does not self-identify as African American, Black, or mixed race with African American or Black
* If the primary caregiver (female caregiver/mother) does not consent to the girls' participation with the male caregiver the girl chooses, the girl will not be able to participate
* Girls will be excluded if they participated in other phases of the research

AIM 2:

• Inability to understand the consent process, and non-employment at a partnering CBO.

About the study

The scientific premise of this research is that individual, interpersonal, and structural factors impact Black girls' sexual reproductive health outcomes (sexually transmitted infection (STI) and Human Immunodeficiency Virus (HIV)) and experience of sexual violence. This study expands STI/HIV prevention programs to include Black male caregivers, a potentially valuable yet underutilized resource to protect Black girls and reduce their exposure to STI/HIV and sexual violence.

What is being tested

Sponsor: University of Illinois at Chicago · Participants: 612 · Started: Sep 2, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT06266416

Locations in the U.S.

IllinoisUniversity of Illinois Chicago, Chicago

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.